The observation of down-regulation of BACE1 and NF-kB following administration of BDC to cells from AD patients as a model system may have utility in the treatment of asymptomatic AD patients.
Curcumin and Novel Synthetic Analogs in Cell-Based Studies of Alzheimer's Disease
Gagliardi S
;Franco V;Sorrentino S;Pandini C;Rota P;Costa A;Pansarasa O;Cereda C.
2018-01-01
Abstract
The observation of down-regulation of BACE1 and NF-kB following administration of BDC to cells from AD patients as a model system may have utility in the treatment of asymptomatic AD patients.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
